Lord, Abbett & Co
OSIR

Lord, Abbett & Co’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Lord, Abbett & Co’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-257,528
Closed -$4.14M – 1155
2013
Q4 		$4.14M Buy
257,528
+46,194
+22% +$736K 0.01% 888
2013
Q3 		$3.52M Buy
+211,334
New +$3.12M 0.01% 874

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Lord, Abbett & Co's OSIR Position: Q1 2014 in Review

Lord, Abbett & Co sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2014, closing a stake of 257,528 shares — an estimated $4.14M sold.

Lord, Abbett & Co first reported a position in OSIR in Q3 2013 and held it in 2 quarters. The position peaked at $4.14M in Q4 2013. 63 funds tracked by Wall St. Rank hold OSIR as of Q1 2014.

  • Lord, Abbett & Co reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Lord, Abbett & Co sold 257,528 Osiris Therapeutics, Inc. Common Stock shares in Q1 2014, an estimated $4.14M.
  • Lord, Abbett & Co first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2013 and held it in 2 quarters.
  • Lord, Abbett & Co's Osiris Therapeutics, Inc. Common Stock position peaked at $4.14M in Q4 2013.
  • 63 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2014.

Based on Lord, Abbett & Co's 13F filing for Q1 2014, filed 15 May 2014.